Status:
TERMINATED
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
The Foundation for Barnes-Jewish Hospital
Conditions:
Hereditary Breast and Ovarian Cancer
Lynch Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to learn how cancer care providers can help their patients communicate the need for genetic testing in families with inherited cancer syndromes.
Eligibility Criteria
Inclusion
- Documentation of HBOC or Lynch-associated "pathogenic/ likely pathogenic" mutation per American College of Medical Genetics and Genomics criteria (1)
- Diagnosis of one or more invasive cancers: epithelial ovarian, fallopian tube, primary peritoneal, breast, colorectal, endometrial
- Mutation listed in NCCN guidelines with at least Category 2A evidence for intervention
- Over the age of 18
- Psychological ability and general health that permits completion of study requirements and follow-up
- Willingness to complete follow-up surveys in person, electronically, or by telephone for up to 6 months
Exclusion
- "Variant of undetermined significance," "likely benign" or "benign" variant per ACMGG criteria
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2024
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04508764
Start Date
April 9 2021
End Date
March 20 2024
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110